Scarica l'app Stockscreener
3.10
4.32%
-0.14
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.24
Aprire:
$3.3
Volume 24 ore:
77,481
Relative Volume:
1.98
Capitalizzazione di mercato:
$5.08M
Reddito:
-
Utile/perdita netta:
$-36.46M
Rapporto P/E:
-1.2917
EPS:
-2.4
Flusso di cassa netto:
$-30.20M
1 W Prestazione:
-22.50%
1M Prestazione:
-27.74%
6M Prestazione:
+75.64%
1 anno Prestazione:
-26.54%
Intervallo 1D:
$3.0801
$3.38
Intervallo di 1 settimana:
$3.0801
$3.9984
Portata 52W:
$1.3137
$6.20
Alaunos Therapeutics Inc Stock (TCRT) Company Profile
Nome
Alaunos Therapeutics Inc
Settore
Industria
Telefono
(346) 355-4099
Indirizzo
2617 BISSONNET ST, HOUSTON
Confronta TCRT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TCRT
Alaunos Therapeutics Inc
|
3.10 | 6.56M | 0 | -36.46M | -30.20M | -2.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Alaunos Therapeutics Inc Stock (TCRT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-10-04 | Ripresa | Wells Fargo | Overweight |
Alaunos Therapeutics Inc Borsa (TCRT) Ultime notizie
What drives Alaunos Therapeutics Inc. stock priceFree Stock Market Real-Time Monitoring - Autocar Professional
What analysts say about Alaunos Therapeutics Inc. stockRapid wealth creation - Autocar Professional
Alaunos Therapeutics Inc. Stock Analysis and ForecastHigh-impact stock picks - PrintWeekIndia
Is Alaunos Therapeutics Inc. a good long term investmentMarket-crushing stock picks - Autocar Professional
why alaunos therapeutics inc. stock attracts strong analyst attentionCapital Preservation Investment Ideas - Newser
Alaunos Therapeutics (NASDAQ:TCRT) Shares Up 0.3% – What’s Next? - Defense World
Alaunos Therapeutics appoints Michael A. Jerman to board and audit chair By Investing.com - Investing.com South Africa
Alaunos Therapeutics appoints Michael A. Jerman to board and audit chair - Investing.com
How Alaunos Therapeutics Inc. stock performs during market volatilityFree Exclusive Access to Stock Gurus - Newser
Why Alaunos Therapeutics Inc. stock attracts strong analyst attentionRapid Gain Targets - Newser
What makes Alaunos Therapeutics Inc. stock price move sharplySmart Growth Low Risk Picks - Newser
Alaunos Therapeutics Holds Annual Stockholders Meeting - MSN
Alaunos Therapeutics Secures $25M Equity Purchase Deal - MSN
Alaunos Therapeutics Appoints Holger Weis as New CEO - The Globe and Mail
Alaunos Therapeutics Raises $850,000 in Private Offering - TipRanks
Alaunos Therapeutics Closes Registered Direct Offering - TipRanks
Is Alaunos Therapeutics, Inc. overvalued or undervalued? - MarketsMojo
Alaunos Therapeutics stock slides on $2M equity offering - MSN
Alaunos Therapeutics raises $2 million in registered direct offering - Investing.com
PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading Wall Street Bank Behind Many Leading Crypto Strategies - The Manila Times
PMGC Capital Urges Alaunos Therapeutics to Accept Strategic Financing Opportunity - Nasdaq
PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) - GlobeNewswire
PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading - Bluefield Daily Telegraph
Clean Financing Deal: Top Wall Street Bank Backs Alaunos While Major Investor PMGC Capital Demands Action - Stock Titan
Alaunos Therapeutics Amends Warrant Agreement with Mast Hill - TipRanks
Alaunos Therapeutics, Inc. (NASDAQ:TCRT) Short Interest Update - Defense World
Juvenescence enhances AI drug discovery with Ro5 acquisition - Pharmaceutical Technology
Ziopharm: Q1 Earnings Snapshot - CT Insider
Alaunos Therapeutics (NASDAQ:TCRT) Trading Down 2.4% – Time to Sell? - Defense World
PMGC Capital announces filing to report 5.09% stake in Alaunos Therapeutics - TipRanks
PMGC Capital LLC, a Subsidiary of PMGC Holdings Inc. - GlobeNewswire
Alaunos Therapeutics Inc Azioni (TCRT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.87%
0.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):